Home > Riviste > Minerva Gastroenterology > Fascicoli precedenti > Minerva Gastroenterologica e Dietologica 2020 June;66(2):87-9 > Minerva Gastroenterologica e Dietologica 2020 June;66(2):172-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

SPECIAL ARTICLE   Free accessfree

Minerva Gastroenterologica e Dietologica 2020 June;66(2):172-6

DOI: 10.23736/S1121-421X.20.02697-5

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus

Francesco DI PIERRO 1 , Alexander BERTUCCIOLI 2, Ilaria CAVECCHIA 1

1 Department of Sciences and Research, Velleja Research, Milan, Italy; 2 Department of Biomolecular Sciences, Carlo Bo University of Urbino, Urbino, Italy



The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100,000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.


KEY WORDS: Coronavirus; Severe acute respiratory syndrome coronavirus 2; Middle east respiratory syndrome coronavirus; Shiitake mushrooms; Adjuvants, immunologic

inizio pagina